LUO Yu-qi, GUO Yi, SHEN Ming-zhi, REN Jun. Myocarditis resulting from COVID-19: from pathophysiology to therapeuticsJ. Chinese Heart Journal, 2026, 38(3): 349-353. DOI: 10.12125/j.chj.202307003
    Citation: LUO Yu-qi, GUO Yi, SHEN Ming-zhi, REN Jun. Myocarditis resulting from COVID-19: from pathophysiology to therapeuticsJ. Chinese Heart Journal, 2026, 38(3): 349-353. DOI: 10.12125/j.chj.202307003

    Myocarditis resulting from COVID-19: from pathophysiology to therapeutics

    • Over recent years, COVID-19 pandemic spread across the world and imposed severe health concerns. Myocarditis is a common manifestation for cardiac complication resulting from COVID-19 and is believed to be originated from direct viral infection of cardiomyocytes, multiple system proinflammation syndrome and COVID-19 vaccination. Such myocarditis can be differentially diagnosed using clinical manifestations, cardiac injury biomarkers, ECG chart, echocardiography and MRI examination of myocardium.
    • loading

    Catalog

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return